Protein acylation: mechanisms, biological functions and therapeutic targets

S Shang, J Liu, F Hua - Signal Transduction and Targeted Therapy, 2022 - nature.com
Metabolic reprogramming is involved in the pathogenesis of not only cancers but also
neurodegenerative diseases, cardiovascular diseases, and infectious diseases. With the …

Current development of CBP/p300 inhibitors in the last decade

ZX He, BF Wei, X Zhang, YP Gong, LY Ma… - European Journal of …, 2021 - Elsevier
CBP/p300, functioning as histone acetyltransferases and transcriptional co-factors,
represents an attractive target for various diseases, including malignant tumor. The …

Effects of the acetyltransferase p300 on tumour regulation from the novel perspective of posttranslational protein modification

Q Zeng, K Wang, Y Zhao, Q Ma, Z Chen, W Huang - Biomolecules, 2023 - mdpi.com
p300 acts as a transcription coactivator and an acetyltransferase that plays an important role
in tumourigenesis and progression. In previous studies, it has been confirmed that p300 is …

Therapeutic potential of AMPK signaling targeting in lung cancer: advances, challenges and future prospects

M Ashrafizadeh, S Mirzaei, K Hushmandi… - Life sciences, 2021 - Elsevier
Lung cancer (LC) is a leading cause of death worldwide with high mortality and morbidity. A
wide variety of risk factors are considered for LC development such as smoking, air pollution …

Inactivation of the CIC-DUX4 oncogene through P300/CBP inhibition, a therapeutic approach for CIC-DUX4 sarcoma

D Bosnakovski, ET Ener, MS Cooper, MD Gearhart… - Oncogenesis, 2021 - nature.com
Abstract CIC-DUX4 sarcoma (CDS) is a highly aggressive and metastatic small round type
of predominantly pediatric sarcoma driven by a fusion oncoprotein comprising the …

[HTML][HTML] HBO1 induces histone acetylation and is important for non-small cell lung cancer cell growth

T Chen, H Hao, Y Zhang, X Chen, H Zhao… - … Journal of Biological …, 2022 - ncbi.nlm.nih.gov
We examined the expression and the potential biological function of HBO1 in non-small cell
lung cancer (NSCLC). TCGA and Oncomine databases showed that HBO1 transcripts were …

Pharmacological targeting of CBP/p300 drives a redox/autophagy axis leading to senescence-induced growth arrest in non-small cell lung cancer cells

MSZ Ansari, V Stagni, A Iuzzolino, D Rotili, A Mai… - Cancer gene …, 2023 - nature.com
Abstract p300/CBP histone acetyltransferases (HAT) are critical transcription coactivators
involved in multiple cellular activities. They act at multiple levels in non-small cell lung …

Novel berberine derivatives as p300 histone acetyltransferase inhibitors in combination treatment for breast cancer

R Lai, Z Lin, C Yang, L Hai, Z Yang, L Guo… - European Journal of …, 2024 - Elsevier
Adenoviral E1A binding protein p300 (EP300 or p300) and its similar paralog, cyclic-AMP
response element binding protein (CBP), are important histone acetyltransferases (HAT) …

Characteristics of anticancer activity of CBP/p300 inhibitors–Features of their classes, intracellular targets and future perspectives of their application in cancer …

M Strachowska, A Robaszkiewicz - Pharmacology & Therapeutics, 2024 - Elsevier
Due to the contribution of highly homologous acetyltransferases CBP and p300 to
transcription elevation of oncogenes and other cancer promoting factors, these enzymes …

Steric-Free Bioorthogonal Labeling of Acetylation Substrates Based on a Fluorine–Thiol Displacement Reaction

Z Lyu, Y Zhao, ZY Buuh, N Gorman… - Journal of the …, 2021 - ACS Publications
We have developed a novel bioorthogonal reaction that can selectively displace fluorine
substitutions alpha to amide bonds. This fluorine–thiol displacement reaction (FTDR) allows …